PROPANC BIOPHARMA, INC. (PPCB) Operating income 2016–2025
PROPANC BIOPHARMA, INC. (PPCB) annual operating income history from SEC filings — each fiscal year as reported.
-$57.3MFY2025 · since FY2016: -$6.9M → -$57.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$57.3M | -3628.9% |
| FY2024 | -$1.5M | +13.5% |
| FY2023 | -$1.8M | +10.8% |
| FY2022 | -$2.0M | -9.9% |
| FY2021 | -$1.8M | +48.1% |
| FY2020 | -$3.5M | -33.6% |
| FY2019 | -$2.6M | +34.0% |
| FY2018 | -$4.0M | +31.0% |
| FY2017 | -$5.7M | +16.8% |
| FY2016 | -$6.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice